BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8627598)

  • 21. Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.
    Cody V; Galitsky N; Luft JR; Pangborn W; Blakley RL; Gangjee A
    Anticancer Drug Des; 1998 Jun; 13(4):307-15. PubMed ID: 9627670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
    Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
    J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
    James R; May C; Diers M; Wagner J; McIvor R
    Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophilin-promoted folding of mouse dihydrofolate reductase does not include the slow conversion of the late-folding intermediate to the active enzyme.
    von Ahsen O; Lim JH; Caspers P; Martin F; Schönfeld HJ; Rassow J; Pfanner N
    J Mol Biol; 2000 Mar; 297(3):809-18. PubMed ID: 10731431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
    Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
    Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
    Mareya SM; Sorrentino BP; Blakley RL
    Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics.
    Rana RM; Rampogu S; Abid NB; Zeb A; Parate S; Lee G; Yoon S; Kim Y; Kim D; Lee KW
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32752079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant.
    Sirawaraporn W; Yongkiettrakul S; Sirawaraporn R; Yuthavong Y; Santi DV
    Exp Parasitol; 1997 Nov; 87(3):245-52. PubMed ID: 9371090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
    Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
    Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a fluorescently labeled thermostable DHFR for studying conformational changes associated with inhibitor binding.
    Goodey NM; Alapa MT; Hagmann DF; Korunow SG; Mauro AK; Kwon KS; Hall SM
    Biochem Biophys Res Commun; 2011 Sep; 413(3):442-7. PubMed ID: 21907182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: potential for clinical application.
    Blakley RL; Sorrentino BP
    Hum Mutat; 1998; 11(4):259-63. PubMed ID: 9554740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843.
    Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK
    Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
    Rosowsky A; Forsch RA; Wright JE
    J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
    Cody V; Pace J; Chisum K; Rosowsky A
    Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Searching sequence space: two different approaches to dihydrofolate reductase catalysis.
    Howell EE
    Chembiochem; 2005 Apr; 6(4):590-600. PubMed ID: 15812782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.